Alkemy S.pA. - Proxy form to be appointed representative pursuant to art. 135-undecies TUF Per saperne di più su Alkemy S.pA. - Proxy form to be appointed representative pursuant to art. 135-undecies TUF
Alkemy S.pA. - Proxy form to be appointed representative pursuant to art. 135-novies TUF Per saperne di più su Alkemy S.pA. - Proxy form to be appointed representative pursuant to art. 135-novies TUF
Alkemy SpA-Explanatory Report on the second item on the agenda for the Extraordinary Session of the Shareholders' Meeting convened on April 29th, 2024 Per saperne di più su Alkemy SpA-Explanatory Report on the second item on the agenda for the Extraordinary Session of the Shareholders' Meeting convened on April 29th, 2024
Alkemy SpA-Explanatory Report on the first item on the agenda for the Extraordinary Session of the Shareholders' Meeting convened on April 29th, 2024 Per saperne di più su Alkemy SpA-Explanatory Report on the first item on the agenda for the Extraordinary Session of the Shareholders' Meeting convened on April 29th, 2024
Il Consiglio di Amministrazione ha approvato i risultati dell’esercizio 2023 Per saperne di più su Il Consiglio di Amministrazione ha approvato i risultati dell’esercizio 2023
Alkemy S.p.A. - Explanatory Report on the fourth item on the agenda of the Shareholders' Meeting convened on April 29th, 2024 Per saperne di più su Alkemy S.p.A. - Explanatory Report on the fourth item on the agenda of the Shareholders' Meeting convened on April 29th, 2024
TXT: relazione finanziaria annuale 2023 Per saperne di più su TXT: relazione finanziaria annuale 2023
Alkemy S.p.A. - Explanatory Report on the third item on the agenda of the Shareholders' Meeting convened on April 29th, 2024 Per saperne di più su Alkemy S.p.A. - Explanatory Report on the third item on the agenda of the Shareholders' Meeting convened on April 29th, 2024
Alkemy S.p.A. - Explanatory Report on the second item on the agenda of the Shareholders' Meeting convened on April 29th, 2024 Per saperne di più su Alkemy S.p.A. - Explanatory Report on the second item on the agenda of the Shareholders' Meeting convened on April 29th, 2024
